Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sportsmans Wareh.ho.

Start price
Target price
Perf. (%)
€4.28
01.10.23
€4.50
30.09.25
11.68%
16.10.23

Could be very worthwhile Investment >20% year
RiceBran Technologies

Start price
Target price
Perf. (%)
€2.38
13.09.22
€1.00
13.09.23
-79.79%
14.09.23

Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€12.60
31.08.22
€10.00
31.08.23
-99.43%
01.09.23

Probably not worthwhile Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
08.09.22
€80.00
31.12.24
35.00%
24.06.23

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€16.10
07.05.22
€20.00
07.05.23
222.26%
08.05.23

Could be very worthwhile Investment >20% year
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.50
03.01.23
€30.00
31.12.25
76.00%
05.05.23

Could be very worthwhile Investment >20% year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.97
06.02.23
€27.00
31.12.25
87.64%
05.05.23

Could be very worthwhile Investment >20% year
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€3.98
09.01.23
€8.00
31.12.25
178.89%
05.05.23

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€66.50
30.09.22
€120.00
31.12.24
324.36%
05.05.23

Could be very worthwhile Investment >20% year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€8.64
11.04.23
€9.00
11.04.24
5.93%
12.04.23

Good rating
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€226.45
22.01.23
€260.00
22.01.24
12.85%
04.02.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High valuation
Risky balance sheet
buy
Meridian Bioscience Inc.

Start price
Target price
Perf. (%)
€19.00
28.01.22
€20.00
28.01.23
62.63%
29.01.23

Could be worthwhile Investment >10% per year
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€1.90
10.01.23
€3.00
10.01.24
52.62%
11.01.23

Could be very worthwhile Investment >20% year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

Veru Inc

Start price
Target price
Perf. (%)
€11.67
07.09.22
€7.00
31.12.24
-38.34%
11.11.22

Could be very worthwhile Investment >20% year
buy
Sterling Con

Start price
Target price
Perf. (%)
€24.20
08.11.21
€28.00
08.11.22
35.54%
09.11.22

Could be worthwhile Investment >10% per year
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€10.10
22.08.22
€10.00
22.08.23
-13.85%
23.08.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Energy Recovery

Start price
Target price
Perf. (%)
€17.20
03.08.21
€20.00
03.08.22
24.07%
29.07.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
27.06.22
€1.00
27.06.23
26.17%
09.07.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques